FindTrial
Sign In

Short stay transurethral prostate surgery: A randomized controlled trial comparing bipolar transurethral vaporization of prostate with monopolar transurethral resection

Short stay transurethral prostate surgery: A randomized controlled trial comparing bipolar transurethral vaporization of prostate with monopolar transurethral resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001656
Enrollment
Unknown
Registered
2011-11-04
Start date
2011-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

Two groups:Bipolar transurethral vaporization of prostate vs Monopolar transurethral resection

Sponsors

Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Men aged between 50 to 70, with benign prostatic hyperplasia: 1. American Association of Anesthesiology Class =18 and/or maximal flow rate (Qmax) <=15ml/s, OR o Acute urinary retention.

Exclusion criteria

Exclusion criteria: Previous history of TURP or other forms of intervention for benign prostate hyperplasia: 1. Patient confirmed to have carcinoma of prostate; 2. Patients with neurogenic bladder, bladder stone, diverticula or urethral stricture requiring concomitant surgery.

Design outcomes

Primary

MeasureTime frame
Clinically hospital stay post-surgery;—

Secondary

MeasureTime frame
catheter time, dysuria score and maximal flow at 3, 6, 12 months post-surgery;—

Countries

China

Contacts

Public ContactNG Chi Fai
ngcf@surgery.cuhk.edu.hk+852 26322625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026